[Misoprostol in oral surgery. 112 clinical evaluations].
The efficacy of misoprostol in protecting gastric mucosa during postoperative NSAID therapy was assessed in a sample group of 112 patients of both sexes suffering from gastric pathologies for which they had undergone oral surgery. The analysis of the results confirms the therapeutic efficacy of misoprostol which enabled these patients to conclude the recommended treatment.
Zoccola
G C
GC
Istituto Policattedra di Clinica Odontostomatologica, Università degli Studi di Torino.
Sapino
S
S
D'Addato
A
A
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D016595:Misoprostol / Q000627:therapeutic use*; D011182:Postoperative Care; D013515:Surgery, Oral
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016595:Misoprostol
Misoprostol in chirurgia orale. 112 valutazioni cliniche.